Although complementary and alternative medicine (CAM) is used by many sufferers of headache/migraine, the use of CAM specifically for the treatment of headache/migraine is relatively low in the US, a recent study found. This secondary analysis of data from the 2012 US NHIS examined the use of CAM among migraine/headache sufferers, including the main reasons related to CAM use. The sample of 34,525 adults included 6,558 (18.7%) headache/migraine sufferers. Researchers found:
- Of the headache/migraine sufferers, a substantial proportion (37.6%, n=2,427) used CAM for various conditions; however, CAM use specifically for headache/migraine was much less prevalent (3.3%, n=216).
- Of those who used CAM for headache/migraine, about half used CAM in conjunction with prescription (47.8%, n=100) or over-the-counter medication (55.1%, n=113).
- The most frequently used CAM modality among all headache/migraine sufferers (n=6,558) was manipulative therapy (22.0%, n=1,317), herbal supplementation (21.7%, n=1,389) and mind-body therapy (17.9%, n=1,100).
- The top 3 reasons for using CAM for headache were general wellness (28.7%, n=60/209), improving overall health (26.8%, n=56/209), and reducing stress (16.7%, n = 35/209).
Zhang Y, Dennis JA, Leach MJ, et al. Complementary and alternative medicine use among US adults with headache or migraine: Results from the 2012 National Health Interview Survey. [Published online ahead of print July 25, 2017]. Headache. doi:10.1111/head.13148.
This Week's Must Reads
tDCS: Promising Remedy for MS Fatigue Reduction , Mult Scler; ePub 2017 Sep 22; Charvet, et al
Ocrelizumab Offers Greater Value Than Interferon, J Med Econ; 2017 Oct; Frasco, Shih, Incerti, et al
Surgeries Offer Relief for Neuralgia Pain in MS , Clin Neurol Neurosurg; ePub 2017 Sep 7; Holland, et al
Evidence-Based Cognitive Rehab for Persons with MS, Arch Phys Med Rehab; ePub 2017 Sep 25; Goverover, et al
Particulate Matter Not Linked with MS Risk, Environ Int; ePub 2017 Sep 20; Palacios, et al
Must Reads in Headache & Migraine
Complementary/Alternative Drug Use for Headache, Headache; ePub 2017 Jul 25; Zhang, et al
Headache in Idiopathic Intracranial Hypertension, Headache; ePub 2017 Jul 28; Friedman, Quiros, et al
Body Composition Status Linked with Migraine Risk, Neurology; ePub 2017 Apr 12; Gelaye, Sacco, et al
Expanded FDA Approval for Trokendi XR, Supernus news release; 2017 Apr 5
Higher Migraine Pain Acceptance & Lower Disability, Headache; ePub 2017 Mar 13; Lillis, Thomas, et al